The UK Lung Cancer Coalition (UKLCC) is calling for a doubling
of five-year lung cancer survival rates to 25% by 2025.
Whether you are a health professional working in the forefront
of lung cancer, a patient group, policy maker, health organisation
or member of the public, help us improve outcomes for people living
with lung cancer in the UK.
Lung cancer and mesothelioma service guidance during the COVID-19 pandemic
READ OUR NEW REPORT: COVID-19 Matters - a review of the impact of COVID-19 on the lung cancer pathway and opportunities for innovation emerging from the health system response to the pandemic
Read our blog on new report endorsed by UKLCC providing patient and clinical insights into use of virtual consultations in response to COVID-19.